SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-060388
Filing Date
2022-09-30
Accepted
2022-09-30 07:27:26
Documents
7
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea166507-6k_scisparc.htm 6-K 21747
2 PRESS RELEASE DATED SEPTEMBER 14, 2022, TITLED "SCISPARC ENTERS AGREEMENT TO ACQ ea166507ex99-1_scisparc.htm EX-99.1 11668
3 ASSIGNMENT AND ASSUMPTION AGREEMENT BETWEEN SCISPARC LTD. AND M.R.M MERHAVIT HOL ea166507ex99-2_scisparc.htm EX-99.2 27928
4 ASSET PURCHASE AGREEMENT BETWEEN SCISPARC LTD., ERM LLC AND ITS OWNERS, DATED SE ea166507ex99-3_scisparc.htm EX-99.3 316873
5 SHARE PURCHASE WARRANT ea166507ex99-4_scisparc.htm EX-99.4 69136
6 PRESS RELEASE DATED SEPTEMBER 30, 2022, TITLED "SCISPARC COMPLETES THE ACQUISITI ea166507ex99-5_scisparc.htm EX-99.5 10741
7 PRESS RELEASE DATED SEPTEMBER 22, 2022, TITLED "SCISPARC LTD. AND CLEARMIND MEDI ea166507ex99-6_scisparc.htm EX-99.6 6190
  Complete submission text file 0001213900-22-060388.txt   465475
Mailing Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916
Business Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916 972-3-6103100
SciSparc Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 221282251
SIC: 2834 Pharmaceutical Preparations